vs
DORCHESTER MINERALS, L.P.（DMLP）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是DORCHESTER MINERALS, L.P.的1.7倍（$69.8M vs $41.9M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 38.7%，领先345.4%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 5.4%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 16.2%）
多切斯特矿业有限合伙是一家总部位于美国的上市有限合伙企业，主要收购、持有及管理油气相关的特许权权益、净利润权益、矿产产权等多元化资产组合，资产覆盖美国多个核心陆上油气产区，为合伙份额持有人提供稳定的现金流回报。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
DMLP vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.7倍
$41.9M
营收增速更快
RIGL
高出15.8%
5.4%
净利率更高
RIGL
高出345.4%
38.7%
两年增速更快
RIGL
近两年复合增速
16.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $41.9M | $69.8M |
| 净利润 | $16.2M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | — | 33.2% |
| 净利率 | 38.7% | 384.0% |
| 营收同比 | 5.4% | 21.2% |
| 净利润同比 | 13.7% | 1769.2% |
| 每股收益（稀释后） | — | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DMLPRIGL
| Q4 25 | $41.9M | $69.8M | ||
| Q3 25 | $35.4M | $69.5M | ||
| Q2 25 | $32.4M | $101.7M | ||
| Q1 25 | $43.2M | $53.3M | ||
| Q4 24 | $39.7M | $57.6M | ||
| Q3 24 | $53.5M | $55.3M | ||
| Q2 24 | $37.4M | $36.8M | ||
| Q1 24 | $31.0M | $29.5M |
净利润DMLPRIGL
| Q4 25 | $16.2M | $268.1M | ||
| Q3 25 | $11.2M | $27.9M | ||
| Q2 25 | $12.3M | $59.6M | ||
| Q1 25 | $17.6M | $11.4M | ||
| Q4 24 | $14.2M | $14.3M | ||
| Q3 24 | $36.4M | $12.4M | ||
| Q2 24 | $23.6M | $-1.0M | ||
| Q1 24 | $18.2M | $-8.2M |
毛利率DMLPRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率DMLPRIGL
| Q4 25 | — | 33.2% | ||
| Q3 25 | — | 40.9% | ||
| Q2 25 | — | 60.1% | ||
| Q1 25 | — | 23.9% | ||
| Q4 24 | — | 28.9% | ||
| Q3 24 | — | 25.4% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | -23.6% |
净利率DMLPRIGL
| Q4 25 | 38.7% | 384.0% | ||
| Q3 25 | 31.5% | 40.2% | ||
| Q2 25 | 38.1% | 58.6% | ||
| Q1 25 | 40.9% | 21.5% | ||
| Q4 24 | 35.9% | 24.9% | ||
| Q3 24 | 68.1% | 22.5% | ||
| Q2 24 | 63.2% | -2.8% | ||
| Q1 24 | 58.6% | -27.9% |
每股收益（稀释后）DMLPRIGL
| Q4 25 | — | $14.11 | ||
| Q3 25 | — | $1.46 | ||
| Q2 25 | — | $3.28 | ||
| Q1 25 | — | $0.63 | ||
| Q4 24 | — | $0.82 | ||
| Q3 24 | — | $0.70 | ||
| Q2 24 | — | $-0.06 | ||
| Q1 24 | — | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $41.9M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | — | $391.5M |
| 总资产 | $309.6M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资DMLPRIGL
| Q4 25 | $41.9M | $155.0M | ||
| Q3 25 | $41.6M | $137.1M | ||
| Q2 25 | $36.5M | $108.4M | ||
| Q1 25 | $41.5M | $77.1M | ||
| Q4 24 | $42.5M | $77.3M | ||
| Q3 24 | $56.5M | $61.1M | ||
| Q2 24 | $35.2M | $49.1M | ||
| Q1 24 | $37.7M | $49.5M |
总债务DMLPRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益DMLPRIGL
| Q4 25 | — | $391.5M | ||
| Q3 25 | — | $117.6M | ||
| Q2 25 | — | $81.9M | ||
| Q1 25 | — | $18.6M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | — | $-14.6M | ||
| Q2 24 | — | $-29.9M | ||
| Q1 24 | — | $-31.7M |
总资产DMLPRIGL
| Q4 25 | $309.6M | $513.6M | ||
| Q3 25 | $330.4M | $242.5M | ||
| Q2 25 | $325.6M | $206.7M | ||
| Q1 25 | $349.0M | $176.0M | ||
| Q4 24 | $366.8M | $164.0M | ||
| Q3 24 | $403.4M | $139.4M | ||
| Q2 24 | $176.0M | $128.4M | ||
| Q1 24 | $184.8M | $126.5M |
负债/权益比DMLPRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $34.3M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 2.12× | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DMLPRIGL
| Q4 25 | $34.3M | $22.0M | ||
| Q3 25 | $34.3M | $24.0M | ||
| Q2 25 | $30.5M | $30.5M | ||
| Q1 25 | $33.4M | $-893.0K | ||
| Q4 24 | $31.5M | $14.5M | ||
| Q3 24 | $43.7M | $21.7M | ||
| Q2 24 | $29.4M | $302.0K | ||
| Q1 24 | $28.0M | $-5.0M |
现金转化率DMLPRIGL
| Q4 25 | 2.12× | 0.08× | ||
| Q3 25 | 3.07× | 0.86× | ||
| Q2 25 | 2.47× | 0.51× | ||
| Q1 25 | 1.89× | -0.08× | ||
| Q4 24 | 2.21× | 1.01× | ||
| Q3 24 | 1.20× | 1.75× | ||
| Q2 24 | 1.25× | — | ||
| Q1 24 | 1.54× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DMLP
| Royalties | $34.0M | 81% |
| Other | $7.8M | 19% |
RIGL
暂无分部数据
